Cargando…
A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents
Anti‐IgE treatments, such as omalizumab, have shown promising effects in allergy treatment. Our previous work has shown that individualized omalizumab treatment (OT) allows a safe initiation and rapid up‐dosing of peanut oral immunotherapy (OIT) in peanut‐allergic adolescents. However, the broader i...
Autores principales: | van der Heiden, Marieke, Nopp, Anna, Brandström, Josef, Carvalho‐Queiroz, Claudia, Nilsson, Caroline, Sverremark‐Ekström, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988572/ https://www.ncbi.nlm.nih.gov/pubmed/33244763 http://dx.doi.org/10.1111/sji.13005 |
Ejemplares similares
-
Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents
por: Ödling, Maria, et al.
Publicado: (2023) -
Th9 cells in allergic diseases: A role for the microbiota?
por: Badolati, Isabella, et al.
Publicado: (2019) -
A clinical follow‐up of omalizumab in routine treatment of allergic asthma monitored by CD‐sens
por: Johansson, S. Gunnar O., et al.
Publicado: (2018) -
270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012) -
Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible
por: Glaumann, Susanne, et al.
Publicado: (2013)